Tímea Tőkés

Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy

Balázs Ács, Veronika Zámbó, Laura Vízkeleti et al. · Diagnostic Pathology · 2017 · 96 citations · Full text

AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients

Giulia Bottai, Carlotta Raschioni, Borbála Székely et al. · npj Breast Cancer · 2016 · 58 citations · Full text

Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancer

Kornélia Kajáry, Tímea Tőkés, Magdolna Dank et al. · Nuclear Medicine Communications · 2014 · 47 citations

Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations

Kornélia Kajáry, Zsolt Lengyel, Anna-Mária Tőkés et al. · Pathology & Oncology Research · 2019 · 37 citations · Full text

Defining the design space for freeze-dried orodispersible tablets with meloxicam

Sonia Iurian, Ioan Tomuță, Cătălina Bogdan et al. · Drug Development and Industrial Pharmacy · 2016 · 30 citations